Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Clinical Study of Targeted and Genome-Wide Sequencing

NCT01345513 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01345513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01345513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Clinical Study of Targeted and Genome-Wide Sequencing
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Completed
Start date
March 31, 2011
Completion date
January 21, 2019
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors